HRAS and cancer: A PPI network analysis was used to identify 17 potential targets of saponins aglycone in cancer cells, and the binding modes of saponins aglycone to four of these targets (BRD3, GLO1, CDK6, and HRAS) were confirmed using docking and MD simulations.